Finally, activation of the leptin-aldosterone-neprilysin axis appears to contribute importantly to the natural evolution of HF in T2DM patients with obesity and NT-proBNP levels require more thorough evaluation to predict HFpEF [46]. The gene discussed is NPPB; the disease is obesity disorder.